Mar 31, 2022 / 08:30PM GMT
Operator
Welcome to the conference call hosted by Daré Bioscience to review the company's financial results for the year ended December 31, 2021, and to provide a general business update. This call is being recorded. My name is Catherine, and I'll be your operator today. With us today are Sabrina Martucci Johnson, Dare's President and Chief Executive Officer; John Fair, Dare's Chief Strategy Officer; and Lisa Walters-Hoffert, Dare's Chief Financial Officer. Ms. Johnson, please proceed.
Sabrina Martucci Johnson - DaréBioscience - Inc. - President, CEO, Secretary & Director
Thank you. Good afternoon, and welcome to our full year 2021 financial results and business update call for Dare Bioscience. Our plan today is to review last year's results, discuss development since our last call in November, and used the time to highlight objectives and milestones anticipated for 2022 as well as other insights for the year.
Before we begin, I'd like to remind you that today's discussion will include forward-looking statements within the meaning
Q4 2021 Dare Bioscience Inc Earnings Call Transcript
Apr 01, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers